DescriptionFounded in 1974, Erregierre is a leading manufacturer of APIs and also performs custom synthesis.
FDA StatusFDA Inspected, no Form 483 issued.
Therapeutic ClassesAnti-fungals, anti-hypertensives, anti-inflammatories, anti-allergic, gastrointestinals, expectorants, CNS and cardiovasculars.
Facilities / CapabilitiesR&D, full production, custom manufacturing and chiral synthesis. Erregierre has two production plants – one in San Paolo D’Argon and the other in Sovere. It can perform several kinds of reactions from -80°C to + 220°C, and explosion-proof facilities include 500 to 10,000 liter glass-lined and stainless steel reactors. The GMP pilot plant has reactors ranging in capacity from 50 to 2,500 liters.